drugset / Trial / NCT00825396
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
Timeline
- Start
- 2007-04
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-KAD Ophthalmic Solution | Unknown | — | Topical |